dactinomycin has been researched along with Aesthesioneuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Constantinidis, J; Dimmler, A; Iro, H; Koch, M; Strauss, C | 1 |
| Dehesdin, D; Fréger, P; Laquerrière, A; Proust, F; Velche-Haag, B | 1 |
1 review(s) available for dactinomycin and Aesthesioneuroblastoma
| Article | Year |
|---|---|
[Ewing's sarcoma of the ethmoid bone. Case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dacarbazine; Dactinomycin; Diagnostic Errors; Doxorubicin; Esthesioneuroblastoma, Olfactory; Ethmoid Bone; Facial Pain; Humans; Magnetic Resonance Imaging; Male; Multiple Sclerosis; Radiotherapy, Adjuvant; Sarcoma, Ewing; Skull Neoplasms; Vincristine; Vision Disorders | 2002 |
1 other study(ies) available for dactinomycin and Aesthesioneuroblastoma
| Article | Year |
|---|---|
[Long-term experiences in the therapy of esthesioneuroblastoma].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Dactinomycin; Doxorubicin; Esthesioneuroblastoma, Olfactory; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Male; Middle Aged; Nasal Cavity; Neoplasm Staging; Nose Neoplasms; Prognosis; Radiotherapy Dosage; Retrospective Studies; Survival Analysis; Time Factors; Vincristine | 2006 |